The FDA has cleared Medtronic to market its Affinity Fusion blood oxygenation device, which is used to replicate lung function during open-heart procedures. The device, which already has marketing clearance in Europe, filters out air and particles from blood during oxygenation and features a curved venous inlet tube to minimize turbulence in blood flow.

Related Summaries